PNC Financial Services Group
PRAX icon

PNC Financial Services Group’s Praxis Precision Medicines PRAX Stock Holding History

PNC Financial Services Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$533K Buy
1,593
+640
+67% +$203K ﹤0.01% 1742
2026
Q1 		$307K Buy
953
+239
+33% +$73.9K ﹤0.01% 2027
2025
Q4 		$210K Buy
714
+690
+2,875% +$128K ﹤0.01% 2276
2025
Q3 		$1.27K Hold
24
– – ﹤0.01% 4627
2025
Q2 		$1.01K Buy
24
+19
+380% +$724 ﹤0.01% 4563
2025
Q1 		$189 Buy
5
+3
+150% +$187 ﹤0.01% 4783
2024
Q4 		$154 Buy
+2
New +$145 ﹤0.01% 4674

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

PNC Financial Services Group's PRAX Position: Q2 2026 in Review

PNC Financial Services Group increased its Praxis Precision Medicines (PRAX) stake by 67% in Q2 2026, buying an estimated $203K and bringing the position to 1,593 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #1742.

PNC Financial Services Group first reported a position in PRAX in Q4 2024 and has held it in 7 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • PNC Financial Services Group held 1,593 shares of Praxis Precision Medicines worth $533K as of Q2 2026.
  • PNC Financial Services Group bought 640 Praxis Precision Medicines shares in Q2 2026, an estimated $203K.
  • Praxis Precision Medicines made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1742 holding.
  • PNC Financial Services Group first reported a position in Praxis Precision Medicines in Q4 2024 and has held it in 7 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.